Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for February 2011
February 1, 2011
- Genzyme to Share Non-Public Information With Sanofi-Aventis as Deal Negotiations Continue
- Pfizer Forced to Deny Reports of Avoiding VAT: Accusation of Elaborate Euros 300 Million Tax Scheme: German Authorities Investigated Six Managers
- Johnson & Johnson Receives Approval From European Commission for Crucell Acquisition
- Biogen Idec Reports Full Year and Fourth Quarter 2010 Results
- Apeiron Acquires Rights for A Phase Ii Biologic Against Neuroblastoma and Other Cancers From Merck KGaA, Germany
- Pfizer Reports Fourth-Quarter and Full-Year 2010 Results; Provides 2011 Financial Guidance and Updates 2012 Financial Targets
- Biogen Idec Reports Full Year and Fourth Quarter 2010 Results
- Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.
- Pfizer Announces New $5 Billion Share Repurchase Program
- Finland: Link Between Swine Flu Shot, Narcolepsy
February 2, 2011
- Report: How The War On Fake Drugs Risks Harming The Poor
- Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
- Pfizer Layoffs Seen As Strategic
- Court Urged to Uphold Challenge to FDA Bioequivalence Rule
- Roche: Solid overall results
- Icagen Announces Lifting of Clinical Hold of ICA-105665
- Cancer Drug Used in Combination with Other Therapies Associated With Increased Risk of Death
- Allergan Reports Fourth Quarter 2010 Operating Results
- Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
- Wide Variation Exists in Receipt of Recommended Medications For Medicare Managed Care Patients With Rheumatoid Arthritis
- H. D. Smith Aligns Leadership Positions to Fill Three Senior Roles
- Frazier Healthcare Announces Growth Equity Team Promotions
- HCPC Expands Annual Event to Drive Pharma Collaboration
- Barbara Ann Karmanos Cancer Center Names Dr. David Gorski Leader of Breast Multidisciplinary Team
- Pharmaceutical Industry Bracing for Record Patent Expiries, EvaluatePharma Data Reveals
- AbelsonTaylor Promotes Kaelin Dezelan and Paul Tursky to Account Director
February 3, 2011
- Merck Announces Fourth Quarter and Full Year 2010 Financial Results
- Possible Harm to Patients Looked at
- Danish Drug Maker Novo Nordisk's 4th Quarter Profits Soar 70 Per Cent but Outlook Is Cut
- CIT appoints Dr. François Spézia as head of its reproductive toxicology department
- GSK and Theravance Announce Progression of LAMA/LABA Combination Treatment Into Phase III Development for COPD
- Pediatric clinical trial expert joins INC Research
- GSK results announcement for the fourth quarter
- Epocrates, Inc. Appoints Former Pfizer Executive Peter Brandt to Board of Directors
- Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax
- With Renewed Vision, Spectrum Welcomes Back Familiar Talent
- With Renewed Vision, Spectrum Welcomes Back Familiar Talent
- GCI Health Adds Consumer Health Experts
- Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
- Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
February 4, 2011
- FDA Drug Safety Communication: Avandia (rosiglitazone) labels now contain updated information about cardiovascular risks and use in certain patients
- Affymax Announces Appointment of Herb Cross as Chief Financial Officer
- Galapagos and Merck & Co., Inc. agree to end strategic alliances
- Bohai Pharmaceuticals Appoints Anthony Chan and Gene Hsiao to Board of Directors
- New Co-Promotion Agreements for Rheumatoid Arthritis Products In Japan
- Hologic Receives Approval for Premature Birth Drug
- Teva Reports FDA Warning on Jerusalem Facility
- AstraZeneca Slips As Brilinta Faces Six Month Wait for Possible US Approval
- Anavex strengthens management team with addition of VP, Clinical Development & Medical Affairs
- FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
- ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors
- Anavex strengthens management team with addition of VP, Clinical Development & Medical Affairs
- Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
- Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
February 7, 2011
- Astrazeneca to Halt Phase III Study With Zibotentan
- Pfizer Cuts May Foreshadow Bad News For Groton Site
- Sanofi, Genzyme Closer To $74-A-Share Deal
- Shionogi-ViiV Healthcare Starts Phase III Trial for "572-Trii" Fixed-Dose Combination HIV Therapy
- Docs Speaking for Drug Companies on A Variety of Topics [the Times-Tribune, Scranton, Pa.]
- Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin
- Were $60 Million Of Incentives For Pfizer Worth It?
- Shire Warns of Drug Losses
- Filing Gives A Glimpse of Lilly Executives' Pay
- AstraZeneca Halts Phase III Trial of Zibotentan in Non-Metastatic Castrate Resistant Prostate Cancer
- Josephine Martin Joins PhRMA as Exec VP of Public Affairs
- FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act
- Glaxo Set To Pay Out After Diabetes Drug Linked To Heart Attacks (GSK)
- GSK revises US Avandia label to include new restrictions on use
- Pfizer To Acquire Ferrosan's Consumer Healthcare Business
February 8, 2011
- Gilead Reports Patent Challenge on Tamiflu
- Lundbeck expands its commercial opportunities in Canada and Latin America
- Valeant Pharmaceuticals Announces License of Aczone (dapsone) Gel 5% In Canada
- Teva Reports Full Year and Fourth Quarter 2010 Results
- Casey, Klobuchar Introduce Bill to Address Unprecedented Prescription Drug Shortages
- Antipsychotics for Schizophrenia Associated With Subtle Loss in Brain Volume
- Gilead Reports Patent Challenge on Tamiflu
- Teva Provides 2011 Non-GAAP Financial Outlook
- Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
- Omnicom Group's Diversified Agency Services (DAS) Acquires Communispace
February 9, 2011
- Sanofi Chief Says Talks With Genzyme Moving Ahead
- sanofi-aventis: Solid Results in 2010
- School: Drug Trial Suicide Matter Closed
- Elan Reports Fourth Quarter and Full-Year 2010 Financial Results
- GlaxoSmithKline Moving to New Building at Philadelphia Navy Yard
- Takeda Enrolls Clinical Trial Subject in Phase 3 Study of Alogliptin in China
- UCB and PDL BioPharma Resolve Patent Disputes
- Teva: Qnaze Met Goal in Perennial Allergy Study
February 10, 2011
- Merck Aims to Significantly Increase the Proportion of Women in Management
- Shire: Outstanding 2010 results: Non GAAP EPS up 21% to $4.23. Good earnings growth expected in 2011.
- Valeant Pharmaceuticals Announces Acquisition of Cholestagel in Canada
- PPD Casts Wide Net in Search for New CEO
- Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
- Sanofi CEO Upbeat About Genzyme Deal
- Merck Serono Launches Unitems.Net - A Pioneering Social Network And Online Resource For the Multiple Sclerosis Community
- Cephalon Signs Alba Therapeutics Option Agreement
- Idenix Pharmaceuticals Provides Updates on Three Clinical Development Programs
- Orexigen Therapeutics Announces Corporate Realignment
- Idenix Tumbles On HIV Setback
February 11, 2011
- Mannkind Lays Off 179 Workers; Loses $38.3 Million in 4Q
- Lilly Announces Senior Leadership Changes
- Klobuchar Urges FDA to Address Shortage of Shingles Vaccine
- Cuts Disastrous for Brain Science Research, Academics Warn
- Galderma Gets Competition Approvals to Buy Q-Med
- Tufts Launches Institute for Biopharmaceutical Partnerships
February 14, 2011
- Merck to Add 150 Workers This Year
- PerkinElmer Acquires chemagen Biopolymer-Technologie AG
- The Medicines Company and WilmerHale Law Firm Reach Settlement Agreement
- Sanofi-Aventis Seeks1 Billion Euro Eye-Care Acquisitions
- Eisai Concludes Japan License Agreement for New Aricept Transdermal Formulation
- QPS Expands Into Toxicology Services With Acquisition of the Preclinical Unit of DCB Taiwan
- Pantarhei Biosciences Makes Proposal to Merck
- Mesoblast Limited Issues New Equity To Cephalon Inc., Receives Further Cash Injection
- Adventrx Signs Definitive Agreement to Acquire SynthRx Inc.
- K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue Warrants in Connection With Restructuring its Senior Secured Credit Facility
- Merck Wins First FOSAMAX (alendronate sodium) State Court Trial
February 15, 2011
- Merck Wins Lawsuit Brought By Fosamax Patient
- Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
- Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
- Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology(TM)
- Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers
- Watson Fourth Quarter 2010 Net Revenue Increases 21% to $953 Million
- Daiichi Sankyo, Inc. Acquires First US-Based Packaging and Manufacturing Facility
- Sanofi, Genzyme Deal As Soon As Tomorrow
February 16, 2011
- Sanofi-Aventis to Buy U.S. Biotechnology Firm Genzyme for $20.1 Billion
- Merck Finds No Buyer for Dutch Organon Unit
- Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year
- Nadler Pushes to End Tax Breaks for Pharmaceutical Companies
- Icagen CEO to Take Pay Cut
- Genzyme Turns Into Giant Under CEO
- Drug May Slow Growth Of Early Prostate Cancer; Could Make 'Watchful Waiting' Appealing
- United Therapeutics Could Triple Work Force
- Daiichi Sankyo to Add 80 Jobs in Pa. Plant
- Novo Nordisk Receives Subpoena in the US
- Astellas to Assume Full Commercial Responsibility for VESIcare
February 17, 2011
- GSK Trimming Triangle Jobs
- U.S. Marshals Seize Auralgan Otic Solution
- Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
- Solvay: Strong Growth of the Operating Result for Chemicals and Plastics Activities REBIT for Continuing Activities up by 75% in the 4th Quarter of 2010 (EUR 155 million)
- Aveo Pharma, Astellas in $1.3 Billion Cancer Drug Deal
February 18, 2011
- FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor
- Genzyme Workers Now Wait ; It Could Take Months Before Impact of Sale is Felt by Local Employees
- Louisiana AG Sues Glaxosmithkline Over Avandia
- European Committee OKs Novartis Drug Rasilamlo
February 22, 2011
- AlphaRx Terminates Letter of Intent with Pacific Orient Capital Inc.
- Johnson & Johnson Completes Crucell Tender Offer and Declares it Unconditional
- Forest Laboratories to Acquire Clinical Data, Inc.
- Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million
- Merck FY2010 Profit After Tax Climbs 70% to EUR 642 Million
- Pharmaceutical Supply Chains are Due for a Radical Overhaul Says PwC
- Germany's Merck Says 4th-Quarter Earnings Down 18 Per Cent, but Shares Rise on Bright Outlook
- Drug Shortages Prompt Hospitals to Use Older Treatments, Pay More When They Do Find A Supply
- Questions and Answers on the Supply Shortage of Simponi Pre-Filled Pens
- US High Court OKs Limits on Child Vaccine Lawsuits
- ProStrakan Bought By Kyowa Hakko Kirin
February 23, 2011
- FDA Drug Safety Communication: Antipsychotic Drug Labels Updated on Use During Pregnancy and Risk of Abnormal Muscle Movements and Withdrawal Symptoms in Newborns
- Glaxo Pays $11.8 Million to N.C. in Settlement
- ONGLYZA (saxagliptin) U.S. Label Update Provides Further Evidence Regarding Use in Renally Impaired Adults with Type 2 Diabetes
- Elan and PPD Announce Global Business Relationship in Drug Development
- Pfizer, Nigerians Settle Trovan Lawsuit
- Renegade Quebec Doctor Warns of 'Ethical Bankruptcy' of Health-Care System
- FDA Warns Sanofi Aventis Over Manufacturing Facility
- Takeda Voluntarily Recalls its Anti-inflammatory Enzyme Preparation, Dasen in Japan
- CARBOGEN AMCIS AG Announces Plan to Restructure
- Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
- Pain-Management Market Projected to Grow to $60 Billion: PharmaLive Special Report
February 24, 2011
- Pain-Management Market Projected to Grow to $60 Billion: PharmaLive Special Report
- Pain-Management Market Projected to Grow to $60 Billion: PharmaLive Special Report
- Abbott Wins Appeal in $1.67 Billion Humira Patent Infringement Case
- Drug Fails to Win Cancer Approval
- U.S. Supreme Court To Hear Arguments Feb. 28 in Stanford V. Roche
- Drug Marketing Increases Risk Of Illness, Study Finds
- Record Number of Medicines in Development for Rare Diseases
- Suitors Reportedly Preparing Bids for Astra Tech
- FDA Grants Genentech a Hearing on Avastin's Use for Metastatic Breast Cancer in the United States
February 25, 2011
- Ipsen and Biomérieux Enter into a Broad Partnership in Personalized Medicine
- Elan and Celgene Enter into Settlement and License Agreement Related to Abraxane
- Samsung Group, Quintiles to Form Drug Venture
- Shire Gets New Challenge on ADHD Drug Adderall XR
- Minnesota Loans $250,000 for Biovest Expansion
February 28, 2011
- Novartis Completes Tender Offer For Genoptix, Announces Subsequent Offering Period
- Novartis Shareholders to Vote on Alcon Merger on 8 April
- Glaxo Move is a Challenge for Center City Landlords
- Lilly Agrees to $337K in Federal Fines for Hazardous Air Pollution
- Johnson & Johnson Slashes CEO Bonus After Year of Product Recalls
- PDL Biopharma Settles Legal Dispute With Novartis
- Bayer Achieves Sales Growth in North America
- Fujifilm to Acquire Merck Biomanufacturing Network
- Bayer AG Reports Q4 Net Loss of Mln
- Pfizer Receives European OK for Drug Xiapex
